Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mami Iida

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Journal of Cardiology|August 27, 2013
Design of prospective study of acute coronary syndrome hospitalization after smoking ban in public places in Hyogo prefecture: comparison with Gifu, a prefecture without a public smoking banYukihito Sato, Shinya Minatoguchi, Kazuhiko Nishigaki, et al.
Internal Medicine (Tokyo, Japan)|May 1, 2020
Cigarette Smoking Cessation Temporarily Enhances the Release of Phosphorylated-HSP27 from Human PlateletsTakashi Onuma, Mami Iida, Yuko Kito, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 23, 2023
Long-Term Follow-up Study of Hospitalizations for Acute Coronary Syndrome in Kobe-City and Other Districts Under the Hyogo Smoking Ban Legislation　- A Nationwide Database StudyMichikazu Nakai, Yoshitaka Iwanaga, Yoko Sumita, et al.
Journal of Atherosclerosis and Thrombosis|May 14, 2013
Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 versionTamio Teramoto, Jun Sasaki, Shun Ishibashi, et al.
Journal of Atherosclerosis and Thrombosis|December 17, 2013
Other types of primary hyperlipoproteinemia(hyperlipidemia). Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 versionTamio Teramoto, Jun Sasaki, Shun Ishibashi, et al.
Journal of Atherosclerosis and Thrombosis|December 17, 2013
Coronary artery disease. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 versionTamio Teramoto, Jun Sasaki, Shun Ishibashi, et al.
Journal of Atherosclerosis and Thrombosis|December 17, 2013
Treatment B) drug therapy: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 versionTamio Teramoto, Jun Sasaki, Shun Ishibashi, et al.
Journal of Atherosclerosis and Thrombosis|July 30, 2013
Cardiovascular disease risk factors other than dyslipidemia. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan - 2012 versionTamio Teramoto, Jun Sasaki, Shun Ishibashi, et al.
Journal of Atherosclerosis and Thrombosis|July 30, 2013
Diagnostic criteria for dyslipidemiaTamio Teramoto, Jun Sasaki, Shun Ishibashi, et al.
Journal of Atherosclerosis and Thrombosis|July 30, 2013
Absolute risk of cardiovascular disease and lipid management targetsTamio Teramoto, Jun Sasaki, Shun Ishibashi, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Journal of Cardiology|August 27, 2013
Design of prospective study of acute coronary syndrome hospitalization after smoking ban in public places in Hyogo prefecture: comparison with Gifu, a prefecture without a public smoking banYukihito Sato, Shinya Minatoguchi, Kazuhiko Nishigaki, et al.
Internal Medicine (Tokyo, Japan)|May 1, 2020
Cigarette Smoking Cessation Temporarily Enhances the Release of Phosphorylated-HSP27 from Human PlateletsTakashi Onuma, Mami Iida, Yuko Kito, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 23, 2023
Long-Term Follow-up Study of Hospitalizations for Acute Coronary Syndrome in Kobe-City and Other Districts Under the Hyogo Smoking Ban Legislation　- A Nationwide Database StudyMichikazu Nakai, Yoshitaka Iwanaga, Yoko Sumita, et al.
Journal of Atherosclerosis and Thrombosis|May 14, 2013
Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 versionTamio Teramoto, Jun Sasaki, Shun Ishibashi, et al.
Journal of Atherosclerosis and Thrombosis|December 17, 2013
Other types of primary hyperlipoproteinemia(hyperlipidemia). Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 versionTamio Teramoto, Jun Sasaki, Shun Ishibashi, et al.
Journal of Atherosclerosis and Thrombosis|December 17, 2013
Coronary artery disease. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 versionTamio Teramoto, Jun Sasaki, Shun Ishibashi, et al.
Journal of Atherosclerosis and Thrombosis|December 17, 2013
Treatment B) drug therapy: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 versionTamio Teramoto, Jun Sasaki, Shun Ishibashi, et al.
Journal of Atherosclerosis and Thrombosis|July 30, 2013
Cardiovascular disease risk factors other than dyslipidemia. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan - 2012 versionTamio Teramoto, Jun Sasaki, Shun Ishibashi, et al.
Journal of Atherosclerosis and Thrombosis|July 30, 2013
Diagnostic criteria for dyslipidemiaTamio Teramoto, Jun Sasaki, Shun Ishibashi, et al.
Journal of Atherosclerosis and Thrombosis|July 30, 2013
Absolute risk of cardiovascular disease and lipid management targetsTamio Teramoto, Jun Sasaki, Shun Ishibashi, et al.
Pageof 6